Dubuque Bank & Trust’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-1,470
Closed -$241K – 282
2021
Q2
$241K Hold
1,470
– – 0.03% 232
2021
Q1
$221K Hold
1,470
– – 0.03% 244
2020
Q4
$223K Sell
1,470
-115
-7% -$16.4K 0.03% 233
2020
Q3
$215K Hold
1,585
– – 0.03% 189
2020
Q2
$217K Buy
+1,585
New +$202K 0.03% 189
2019
Q2
– Sell
-1,585
Closed -$177K – 373
2019
Q1
$177K Hold
1,585
– – 0.03% 169
2018
Q4
$153K Sell
1,585
-695
-30% -$73.8K 0.03% 170
2018
Q3
$278K Hold
2,280
– – 0.04% 136
2018
Q2
$250K Hold
2,280
– – 0.04% 160
2018
Q1
$243K Buy
2,280
+555
+32% +$61.5K 0.04% 183
2017
Q4
$184K Hold
1,725
– – 0.03% 231
2017
Q3
$192K Hold
1,725
– – 0.03% 218
2017
Q2
$178K Buy
1,725
+480
+39% +$47.3K 0.04% 210
2017
Q1
$122K Buy
+1,245
New +$119K 0.03% 250
2016
Q3
– Sell
-3,000
Closed -$257K – 555
2016
Q2
$257K Hold
3,000
– – 0.05% 158
2016
Q1
$261K Sell
3,000
-69
-2% -$6.17K 0.05% 160
2015
Q4
$346K Buy
3,069
+3,000
+4,348% +$326K 0.07% 160
2015
Q3
$7K Sell
69
-171
-71% -$20.5K ﹤0.01% 470
2015
Q2
$30K Buy
+240
New +$28.7K 0.01% 366

Other funds holding IBB

Dubuque Bank & Trust's IBB Position: Q3 2021 in Review

Dubuque Bank & Trust sold out of iShares Biotechnology ETF (IBB) in Q3 2021, closing a stake of 1,470 shares — an estimated $241K sold.

Dubuque Bank & Trust first reported a position in IBB in Q2 2015 and held it in 19 quarters. The position peaked at $346K in Q4 2015. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

  • Dubuque Bank & Trust reported no remaining iShares Biotechnology ETF position as of Q3 2021 after selling out during the quarter.
  • Dubuque Bank & Trust sold 1,470 iShares Biotechnology ETF shares in Q3 2021, an estimated $241K.
  • Dubuque Bank & Trust first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 19 quarters.
  • Dubuque Bank & Trust's iShares Biotechnology ETF position peaked at $346K in Q4 2015.
  • 855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Dubuque Bank & Trust's 13F filing for Q3 2021, filed 9 Nov 2021.